• Follow the Money: Remote Patient Monitoring, Real-World Data Networks, Trial Diversity

    Clinical Research News | PatientsLikeMe raises a new round of funding to expand, and several companies get investments for remote patient monitoring and medication adherence. Mount Sinai leads team tasked with decreasing the disparities in cancer trials. And new investment funds for late-stage companies and public health.

    Apr 1, 2021

  • How Cerevel Therapeutics Put Hybrid Trials Into Practice

    Clinical Research News | Cerevel Therapeutics is looking at new studies in a different way after test-driving an assortment of virtual trial options when the pandemic hit. Remote site initiation visits and remote monitoring will be permanent fixtures moving forward, and the incorporation of home health visits also appears promising, according to Laura Whitmore, director of clinical operations oversight

    Mar 31, 2021

  • Interest Brewing In A One-Stop Platform For Trial Participants

    Clinical Research News | A panel discussion on the move toward “platform thinking” in pharma roused lively discussion and exchange with attendees at the recent Summit for Clinical Ops Executives (SCOPE). Interest was particularly high in development of a common platform catering to the needs of patients and disconnected from any drug, protocol, or sponsor.

    Mar 30, 2021

  • Takeda Using Chatbot To Improve Patient-Centricity And Trial Design

    Clinical Research News | Takeda Pharmaceuticals has developed a digital chatbot assistant to provide integrated and continuous support for patients with chronic diseases at risk of serious event occurrences and frequent emergency room visits. The learnings are expected to help clinical trials become more patient-centric and less labor-intensive to conduct.

    Mar 29, 2021

  • The Importance of Early Phase Trials in Precision Oncology

    Clinical Research News | Nowadays, drug development in oncology is largely centered on the basic premise of precision medicine, according to which targeted agents are used based on the expression of predictive biomarkers. Even though late-phase trials of precision oncology are undergoing transformations, we believe that the greatest impact of precision oncology has been in the design of early-phase trials.

    Mar 25, 2021

  • Data Exchange Standards Are Focus Of TransCelerate’s eSource Initiative

    Clinical Research News | TransCelerate’s eSource initiative supporting decentralized clinical trials aims to add efficiency to the clinical research process by facilitating the exchange of data between sites and sponsors and “filling the gaps” in the primary data interchange standards governing electronic health record (EHR) systems.

    Mar 24, 2021